Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SSY Group Limited Board/Management Information 2011

Aug 26, 2011

50335_rns_2011-08-26_64eda60c-c30b-4704-9ea9-6f6c9914a581.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [283 x 113] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2005)

CHANGE OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND ALTERNATE AUTHORISED REPRESENTATIVE

The board of directors (the “ Board ”) of Lijun International Pharmaceutical (Holding) Co., Ltd. (the “ Company ”) announces that Mr. Sze Wing Kin, Pierre (“ Mr. Sze ”) has resigned as Chief Financial Officer, Company Secretary and Alternate Authorised Representative of the Company with effect from 26 August 2011 in order to pursue other career opportunities. Mr. Sze has confirmed that he has no disagreement with the Board and there are no matters that need to be brought to the attention of The Stock Exchange of Hong Kong Limited or/and the shareholders of the Company in relation to his resignation.

The Board is pleased to announce that Mr. Chow Hing Yeung (“ Mr. Chow ”) has been appointed as Chief Financial Officer, Company Secretary and Alternate Authorised Representative of the Company with effect from 26 August 2011. Mr. Chow is a member of the Hong Kong Institute of Certified Public Accountants. Mr. Chow obtained a Bachelor's degree of Business Administration from the Chinese University of Hong Kong. He has more than 11 years of experience in areas of auditing, accounting and financial management.

1

The Board would like to take this opportunity to express its sincere appreciation to Mr. Sze for his valuable contribution to the Company during his tenure of services and wish him every success and also welcome Mr. Chow for his new appointment.

By order of the Board Wu Qin Chairman

Hong Kong, 26 August 2011

As at the date of this announcement, the Board comprises Mr. Wu Qin, Mr. Qu Jiguang, Mr. Xie Yunfeng, Mr. Huang Chao, Mr. Wang Xianjun, Mr. Duan Wei, Ms. Zhang Guifu, Mr. Bao Leyuan and Ms. Gao Shuping as executive Directors, Mr. Liu Zhiyong as nonexecutive Director, and Mr. Wang Yibing, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as independent non- executive Directors.

2